4-Aminoquinolines - Past, present, and future: A chemical perspective

Pharmacology and Therapeutics

Volumn 77, Issue 1, 1998, Pages 29-58

  O'Neill, Paul M ^a   Bray, Patrick G ^a   Hawley, Shaun R ^a   Ward, Stephen A ^a   Kevin Park, B ^a  

^a UNIVERSITY OF LIVERPOOL   (United Kingdom)

Author keywords

4 Aminoquinolines; Drug metabolism; Mechanism of activity; Resistance; SAR

Indexed keywords

4 AMINOQUINOLINE; AMODIAQUINE; CHLOROQUINE;

DRUG METABOLISM; DRUG TOXICITY; HUMAN; MALARIA; MULTIDRUG RESISTANCE; NONHUMAN; PLASMODIUM FALCIPARUM; PRIORITY JOURNAL; PROPHYLAXIS; REVIEW; STRUCTURE ACTIVITY RELATION;

AMINOQUINOLINES; ANIMALS; ANTIMALARIALS; CHLOROQUINE; DNA; DRUG DESIGN; HEME; HUMANS; MODELS, MOLECULAR; STRUCTURE-ACTIVITY RELATIONSHIP;

EID: 0031965067     PISSN: 01637258     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0163-7258(97)00084-3     Document Type: Review

References (144)

1. 3H chloroquine. Am. J. Pathol. 67: 277-280.
2. Aikawa, M., Hepler, P. K., Huff, C. G. and Sprinz, H. (1966) The feeding mechanism of avian malarial parasites. J. Cell. Biol. 28: 355-373.
3. Andersag, H., Breitner, S. and Jung, H. (1939) Ger. Pat. 683: 692.
4. Asante, C. O., Pollman, K., Menz, B., Backes, J., Spira, D. T. and Jung, A. (1984) A comparative study of hemoglobin degradation in chloroquine-resistant and -sensitive Plasmodium berghei. Geb. Biol. Chem. 365: 961-962.
5. Barlin, G. B., Ireland, S. J., Nguyen, T. M., Kotecka, B. and Rieckmann, K. H. (1994) Potential antimalarials: 21. Mannich base derivatives of 4-[7-chloro(and 7-trifluoromethyl)quinolin-4-ylamino]phenols. Aust. J. Chem. 47: 1553-1560.
6. Barnard, S., Kelly, D. F., Storr, R. C. and Park, B. K. (1993) The effect of fluorine substitution on the hepatotoxicity and metabolism of paracetamol in the mouse. Biochem. Pharmacol. 4: 841-849.
7. Behere, D. V. and Goff, H. M. (1984) High-affinity binding of quinine to iron (III) porphyrins: novel formation of alkoxide complexes from alcohols and amines. J. Am. Chem. Soc. 106: 4945-4950.
8. Bitonti, A. J., Sjoerdsma, A., McCann, P. D., Kyle, D. E., Oduola, A. M., Rossan, R. N., Milhous, W. K. and Davidson, D. E., Jr. (1988) Reversal of chloroquine resistance in the malaria parasite Plasmodium falciparum by desipramine. Science 242: 1301-1303.
9. Blauer, G., Akkawi, M. and Bauminger, E. R. (1993) Further evidence for the interaction of the antimalarial drug amodiaquine with ferriprotoporphyrin IX. Biochem. Pharmacol. 46: 1573-1576.
10. Bray, P. G. and Ward, S. A. (1993) Malaria chemotherapy: resistance to quinoline-containing drugs in Plasmodium falciparum. FEMS Microbiol. Lett. 113: 1-8.
11. Bray, P. G., Howells, R. E., Ritchie, G. Y. and Ward, S. A. (1992) Rapid chloroquine efflux phenotype in both chloroquine-sensitive and chloroquine-resistant Plasmodium falciparum. Biochem. Pharmacol. 44: 1317-1324.
12. Bray, P. G., Boulter, M. K., Ritchie, G. Y. and Ward, S. A. (1994) Relationship of global chloroquine transport and reversal of chloroquine resistance in P. falciparum. Mol. Biol. Parasitol. 63: 87-94.
13. Bray, P. G., Hawley, S. R., Mungthin, M. and Ward, S. A. (1996a) Physico-chemical properties correlated with drug resistance and the reversal of drug resistance in Plasmodium falciparum. Mol. Pharmacol. 50: 1559-1566.
14. Bray, P. G., Hawley, S. R. and Ward, S. A. (1996b) 4-Aminoquinoline resistance of Plasmodium falciparum: insights from the study of amodiaquine uptake. Mol. Pharmacol. 50: 1551-1558.
15. Burckhalter, J. H., Tendwick, J. H., Jones, F. H., Jones, P. A., Holcombe, W. F. and Rawlins, A. L. (1948) Aminoalkylphenols as antimalarials II (heterocyclic-amino)-α-amino-o-cresols: the synthesis of camoquine. J. Am. Chem. Soc. 70: 1363-1373.
16. Childs, G. E., Boudreau, E. F., Milhous, W. K., Wimonwattratee, K., Pooyindee, N., Pang, L. and Davidson, D. E., Jr. (1989) A comparison of the in vitro activities of amodiaquine and desethylamodiaquine against isolates of Plasmodium falciparum. Am. J. Trop. Med. Hyg. 40: 7-11.
17. Chou, A. C., Chevli, R. and Fitch, C. D. (1980) Ferriprotoporphyrin IX fulfills the criteria for identification as the chloroquine receptor of malaria parasites. Biochemistry 19: 1543-1549.
18. Churchill, F. C., Patchen, L. C., Campbell, C. C., Schwartz, I. K., Nguyen-Dinh, P. and Dickson, C. M. (1985) Amodiaquine as a pro-drug: importance of metabolite(s) in the antimalarial effect of amodiaquine in humans. Life Sci. 36: 53-62.
19. Clarke, J. B., Maggs, J. L., Kitteringham, N. R. and Park, B. K. (1990) Detection of IgG antibodies in patients with adverse drug reactions to amodiaquine. Int. Arch. Allergy Immunol. 91: 1335-1342.
20. Coatney, G. R. (1963) Pitfalls in a discovery: the chronicle of chloroquine. Am. J. Trop. Med. Hyg. 12: 121-128.
21. Coatney, G. R., Cooper, W. C., Eddy, N. B. and Greenberg, J. (1953) Survey of Antimalarial Agents. Public Health Monograph, No. 9, Government Printing Office, Washington, DC.
22. Cohen, S. N. and Yielding, K. L. (1965) Inhibition of DNA and RNA polymerase reactions by chloroquine. Proc. Natl. Acad. Sci. USA 54: 521-527.
23. Cohen, S. N., Phifer, K. O. and Yielding, K. L. (1964) Complex formation between chloroquine and ferrihemeic acid in vitro and its effect on the antimalarial action of chloroquine. Nature 202: 805-806.
24. Constantinidis, I. and Satterlee, J. D. (1988a) UV-visible and carbon NMR studies of chloroquine binding to urohemin I chloride and uroporphyrin II in aqueous solutions. J. Am. Chem. Soc. 110: 4391-4395.
25. Constantinidis, I. and Satterlee, J. D. (1988b) UV-visible and carbon NMR studies of quinine binding to urohemin I chloride and uroporphyrin II in aqueous solutions. J. Am. Chem. Soc. 110: 927-932.
26. Cowman, A. F. (1991) The P-glycoprotein homologues of Plasmodium falciparum: are they involved in chloroquine resistance? Parasitol. Today 7: 70-75.
27. Cramer, R. D., III, Patterson, D. E. and Bunce, J. D. (1988) Comparative molecular-field analysis (CoMFA): 1. Effect of shape on binding of steroids to carrier proteins. J. Am. Chem. Soc. 110: 5959-5967.
28. Davey, D. G. (1946) The use of avian malaria for the discovery of drugs effective in the treatment and prevention of malaria: 1. Drugs for causal prophylaxis and radical cure or the chemotherapy of exo-erythrocytic forms. Ann. Trop. Med. Parasitol. 40: 453-471.
29. De, D., Krogstad, F. M., Cogswell, F. B. and Krogstad, D. J. (1996) Aminoquinolines that circumvent resistance in Plasmodium falciparum in vitro. Am. J. Trop. Med. Hyg. 55: 579-583.
30. De Duve, C., De Barsy, T., Poole, B., Trouet, A., Tulkens, P. and Van Hoof, F. (1974) Lysosomotropic agents. Biochem. Pharmacol. 23: 2495-2531.
31. Dorn, A., Stoffel, R., Matile, H., Bubendorf, A. and Ridley, R. G. (1995) Malaria haemozoin/beta-haematin supports haem polymerisation in the absence of protein. Nature 374: 269-271.
32. Egan, T. J., Ross, D. C. and Adams, P. A. (1994) Quinoline antimalarial drugs inhibit spontaneous formation of beta-hematin (malaria pigment). FEBS Lett. 352: 54-57.
33. Elsager, E. F., Gold, E. H., Tendick, F. H., Werbel, L. M. and Worth, D. F. (1964) Amodiaquine N-oxides and other 7-chloro-4-aminoquinoline N-oxides. J. Heterocycl. Chem. 1: 6-10.
34. Endicott, J. A. and Ling, V. (1989) The biochemistry of P-glycoprotein mediated multidrug resistance. Annu. Rev. Biochem. 58: 137-171.
35. Fitch, C. D. (1983) Mode of action of antimalarial drugs. In: Malaria and the Red Cell, Ciba Foundation Symposium 94, pp. 222-232, Evered, D. and Whelan, J. (eds.) Pitman, London.
36. Fitch, C. D. and Chevli, R. (1981) Sequestration of the chloroquine receptor in cell-free preparations of erythrocytes infected with P. berghei. Antimicrob. Agents Chemother. 19: 589-592.
37. Fitch, C. D., Chevli, R., Banyal, H. S., Phillips, G., Pfaller, M. A. and Krogstad, D. J. (1982) Lysis of Plasmodium falciparum by ferriprotoporphyrin IX and a chloroquine-ferriprotoporphyrin IX complex. Antimicrob. Agents Chemother. 21: 819-822.
38. Fitch, C. D., Chevli, R., Kanjangulpan, P., Dutta, P., Chevli, K. and Chou, A. C. (1983) Intracellular ferriprotoporphyrin IX is a lytic agent. Blood 62: 1165-1168.
39. Frisk-Holmberg, M., Bergqvist, Y., Termond, E. and Domej-Nyberg, B. (1984) The single dose kinetics of chloroquine and its major metabolite desethylchloroquine in healthy-subjects. Eur. J. Clin. Pharmacol. 26: 521.
40. Galeazzi, E., Guzman, A., Kluge, A., Morgans, D., Muchowski, J., Jamil-Panah, S., Saavedra, P., Salazar, M. A., Talamas, F. X., Teitelbaum, P., Young, J. and Yamamoto, D. (1994) A congener study of zileuton reveals interesting effects on glucuronidation rates. Bioorg. Med. Chem. Lett. 4: 1437-1442.
41. 3H]chloroquine by drug-sensitive and -resistant strains of the human malarial parasite Plasmodium falciparum. Biochem. Pharmacol. 35: 3805-3812.
42. Geary, T. G., Divo, A. D., Jensen, J. B., Zangwill, M. and Ginsburg, H. (1990) Kinetic modelling of the response of Plasmodium falciparum to chloroquine and its experimental testing in vitro: implications for mechanism of action and resistance to the drug. Biochem. Pharmacol. 40: 685-691.
43. Ginsburg, H. and Geary, T. G. (1987) Current concepts and new ideas on the mechanism of action of quinoline-containing antimalarials. Biochem. Pharmacol. 36: 1567-1576.
44. Ginsburg, H. and Krugliak, M. (1992) Quinoline-containing antimalarials, mode of action, drug resistance and its reversal: an update with unresolved puzzles. Biochem. Pharmacol. 43: 63-70.
45. Ginsburg, H. and Stein, W. D. (1991) Kinetic modelling of chloroquine uptake by malaria-infected erythrocytes. Biochem. Pharmacol. 41: 1463-1470.
46. Gluzman, I. Y., Francis, S. E., Oksman, A., Smith, C. E., Duffin, K. L. and Goldberg, D. E. (1994) Order and specificity of the Plasmodium falciparum hemoglobin degradation pathway. J. Clin. Invest. 93: 1602-1608.
47. Go, M. L., Ngiam, T. I. and Wan, A. S. (1981) Synthesis of some novel amodiaquine analogues as potential antimalarial and antifilarial compounds. J. Med. Chem. 24: 1471.
48. Goldberg, D. E., Slater, A. F., Cerami, A. and Henderson, G. B. (1990) Hemoglobin degradation in the malaria parasite Plasmodium falciparum: an ordered process in a unique organelle. Proc. Nad. Acad. Sci. USA 87: 2931-2935.
49. Goldberg, D. E., Slater A. F., Beavis, R., Chait, B., Cerami, A. and Henderson, G. B. (1991) Hemoglobin degradation in the human malaria pathogen Plasmodium falciparum: a catabolic pathway initiated by a specific aspartic protease. J. Exp. Med. 173: 961-969.
50. Gottesman, M. M. and Pastan, I. (1993) Biochemistry of multidrug resistance mediated by the multidrug transporter. Annu. Rev. Biochem. 62: 385-427.
51. Gutteridge, W. E., Trigg, P. I. and Bayley, P. M. (1972) Effects of chloroquine on Plasmodium knowlesi in vitro. Parasitology 64: 37-45.
52. Hahn, F. E., O'Brien, R. L., Ciak, J., Allison, J. L. and Olenick, J. G. (1966) Studies on the modes of action of chloroquine, quinacrine and quinine on chloroquine resistance. Mil. Med. 131: 1071-1089.
53. Harrison, A. C. (1994) The effect of chemical modification on the metabolism of amodiaquine in the rat. Ph.D. Thesis, University of Liverpool.
54. Harrison, A. C., Kitteringham, N. R., Clarke, J. B. and Park, B. K. (1992) The mechanism of bioactivation and antigen formation of amodiaquine in the rat. Biochem. Pharmacol. 43: 1421-1430.
55. Hawley, S. R., Bray, P. G., O'Neill, P. M., Naisbitt, D. J., Park, B. K. and Ward, S. A. (1996) Manipulation of the N-alkyl substituent in amodiaquine to overcome the verapamil sensitive chloroquine resistance mechanism. Antimicrob. Agents. Chemother. 40: 2345-2349.
56. Heindel, N. D. and Molnar, J. (1970) Synthesis and antimalarial activity of amodiaquine analogues. J. Med. Chem. 13: 156-157.
57. Jaeger, A., Sauder, P., Kopferschmitt, J. and Flech, K. (1987) Clinical-features and management of poisoning due to antimalarial drugs. Med. Toxicol. Adverse Drug Exp. 2: 242-273.
58. Jewell, H., Maggs, J. L., Harrison, A. C., O'Neill, P. M., Ruscoe, J. E. and Park, B. K. (1995) Role of hepatic metabolism in the bioactivation and detoxication of amodiaquine. Xenobiotica 25: 199-217.
59. Kawase, M., Sinhababu, A. K. and Bochardt, R. T. (1990) Mechanism of autooxidation of 5,7-dihydroxytryptamine: effect of fluorine substitution at positions 4 and/or 6. Chem. Pharm. Bull. 38: 2939-2946.
60. Koh, H. L., Go, M. L., Ngiam, T. L. and Mak, J. W. (1994) Conformational and structural features determining in vitro antimalarial activity in some Indolo[3,2-c] quinolines, anilinoquinolines and tetrahydroindolo[3,2-d] benzazepeines. Eur. J. Med. Chem. 29: 107-113.
61. Krogstad, D. J. and Schlesinger, P. H. (1986) A perspective on antimalarial action: effects of weak bases on Plasmodium falciparum. Biochem. Pharmacol. 35: 547-552.
62. Krogstad, D. J., Gluzman, I. Y., Kyle, D. E., Oduola, A. M., Martin, S. K., Milhous, W. K. and Schlesinger, P. H. (1987) Efflux of chloroquine from Plasmodium falciparum: mechanism of chloroquine resistance. Science 235: 1283-1285.
63. Kubo, M., Reasor, M. J. and Hostetler, K. Y. (1985) Mechanism of chloroquine toxicity: inhibition of lysosomal phospholipase-a. Clin. Res. 33: 91.
64. Kuroda, K. (1962) Detection and distribution of chloroquine metabolites in human tissues. J. Pharmacol. 137: 156.
65. Laurent, F., Salvin, S., Chretien, P., Magnaval, J. F., Peyron, F., Sqalli, A., Tufenkji, A. E., Coulais, Y., Baba, H., Campistron, G., Regis, H., Ambrose-Thomas, P., Bryskier, A. and Hovin, C. (1993) Pharmacokinetic and pharmacodynamic study of amodiaquine and its two metabolites after a single oral dose in human volunteers. Arzneimittel Forschung Drug Res. 43: 612-616.
66. Le Bras, J., Deloron, P. and Charmot, G. (1983) Dichloroquinazine (a 4-aminoquinoline): effective in vitro against chloroquine-resistant Plasmodium falciparum. Lancet i: 73-74.
67. Li, Y., Qin, Y., Qu, Y. and Gong, Y. (1981) Hydroxypiperaquine phosphate in treating chloroquine-resistant Plasmodium falciparum. Chin. Med. J. 94: 303-304.
68. Lind, D. E., Levi, J. A. and Vincent, P. C. (1973) Amodiaquine induced agranulocytosis: toxic effects of amodiaquine in bone marrow culture in vitro. Br. Med. J. 14: 58-60.
69. Macomber, P. B., Sprinz, H. and Tousimis, A. J. (1967) Morphological effects of chloroquine on Plasmodium berghei in mice. Nature 214: 937-939.
70. Maggs, J. L., Kitteringham, N. R. and Park, B. K. (1988) Drug protein conjugates: XIV. Mechanism of formation of protein arylating intermediates from amodiaquine, a myelotoxin and hepatotoxin in man. Biochem. Pharmacol. 37: 303-311.
71. Maines, M. D. (1988) Heme-oxygenase: function, multiplicity and clinical applications. FASEB J. 2: 2557-2568.
72. Martin, S. K., Oduola, A. M. and Milhous, W. K. (1987) Reversal of chloroquine resistance in Plasmodium falciparum by verapamil. Science 235: 899-901.
73. McChesney, E. W. (1983) Animal toxicity and pharmacokinetics of hydroxychloroquine Am. J. Med. 75: 11-17.
74. McChesney, E. W. and McAucliff, J. P. (1961) Laboratory studies ot the 4-aminoquinoline antimalarials I: some biochemical characteristics of chloroquine, hydroxychloroquine and SN-7718. Antibiot. Chemother. 11: 800-810.
75. McChesney, E. W., Conway, W. D., Banks, W. F., Rogers, J. E. and Shekoksky, J. M. (1966) Studies of the metabolism of some compounds of the 4-aminoquinoline. J. Pharmacol. Exp. Ther. 151: 482-484.
76. Moreau, S., Perly, B., Chachaty, C. and Deleuze, C. (1985) A nuclear magnetic resonance study of the interactions of antimalarial drugs with porphyrins. Biochim. Biophys. Acta 840: 107-116.
77. Morrison, D. B. and Jeskey, H. A. (1948) Alterations in some constituents of the monkey erythrocyte infected with Plasmodium knowlesi as related to pigment formation. J. Natl. Malar. Soc. 7: 259-264.
78. Naor, Z. and Catt, K. J. (1981) Mechanism of action of gonadotropin-releasing hormone: involvement of phospholipid turnover in luteinizing-hormone release. J. Biol. Chem. 256: 2226-2229.
79. Neftel, K. A., Woodtly, W. and Schmid, M. (1986) Amodiaquine induced agranulocytosis and liver damage. Br. Med. J. 292: 721-723.
80. O'Brien, R. L., Olenick, J. G. and Hahn, F. E. (1966) Reactions of quinine, chloroquine and quinacrine with DNA. Proc. Natl. Acad. Sci. USA 55: 1511-1517.
81. O'Neill, P. M. (1995) The Effect of chemical substitution on the metabolism and antimalarial activity of amodiaquine and primaquine. Ph.D. Thesis, The University of Liverpool.
82. O'Neill, P. M., Harrison, A. C., Storr, R. C., Hawley, S. R., Ward, S. A. and Park, B. K. (1994) The effect of fluorine substitution on the metabolism and antimalarial activity of amodiaquine. J. Med. Chem. 37: 1362-1370.
83. O'Neill, P. M., Tingle, M. D., Mahmud, R., Storr, R. C., Ward, S. A. and Park, B. K. (1995) The effect of fluorine substitution on the haemotoxicity of primaquine. Bioorg. Med. Chem. Lett. 5: 2309-2314.
84. O'Neill, P. M., Hawley, S. R., Storr, R. C., Ward, S. A. and Park, B. K. (1996) The effect of fluorine substitution on the antimalarial activity of tebuquine. Bioorg. Med. Chem. Lett. 6: 391-392.
85. O'Neill, P. M., Willock, D. J., Hawley, S. R., Bray, P. G., Storr, R. C. and Park, B. K. (1997) Synthesis, antimalarial activity and molecular modelling of tebuquine analogues. J. Med. Chem. 40: 437-448.
86. Orjih, A. U., Banyal, N. S., Cheul, R. and Fitch, C. D. (1981) Hemin lyses malaria parasites. Science 214: 667-699.
87. Park, B. K. and Kitteringham, N. R. (1993) Effects of fluorine substitution on drug metabolism: pharmacological and toxicological implications. Drug Metab. Dispos. 26: 605-643.
88. Parker, F. S. and Irwin, J. L. (1952) The interaction of chloroquine with nucleic acids and nucleoproteins. J. Biol. Chem. 199: 897-909.
89. Peters, W. (1970) Chemotherapy and Drug Resistance in Malaria. Academic Press, London and New York.
90. Peters, W. (1987) Chemotherapy and Drug Resistance in Malaria. Vols. I and II. Academic Press, London.
91. Peters, W. and Robinson, B. L. (1992) The chemotherapy of rodent malaria XLVII: studies on pyronaridine and other Mannich base antimalarials. Ann. Trop. Med. Parasitol. 86: 455.
92. Peters, W., Ekong, R., Robinson, B. L., Warhurst, D. C. and Pan, X. Q. (1989) Antihistaminic drugs that reverse chloroquine resistance in Plasmodium falciparum. Lancet ii: 334-335.
93. 3H by Plasmodium knowlesi in vitro. J. Pharmacol. Exp. Ther. 168: 187-192.
94. Pussard, E., Verdier, F., Faurisson, F., Clavier, F., Simon, F. and Gaudebout, C. (1988) Disposition of amopyroquin in rats and rabbits and in vitro activity against Plasmodium falciparum. Antimicrob. Agents Chemother. 32: 568-572.
95. Rathscheck, H. J. (1959) Results of clinical trials on the parenteral application of propaquin (PAM 780), a new antimalarial. Trop. Med. Parasitol. 10: 36-37.
96. Raynes, K., Galatis, D., Cowman, A. F., Tilley, L. and Deady, L. (1995) Synthesis and activity of some antimalarial bisquinolines. J. Med. Chem. 38: 204-206.
97. Rice, E. R., Moghaddam, B., Creveling, C. R. and Kirk, K. L. (1987) Effect of fluorine substitution on the anodic oxidaion of catecholamines and amino acids. Anal. Chem. 59: 1524-1538.
98. Ridley, R. G., Hofheinz, W., Matile, H., Jaquet, C., Dorn, A., Masciadri, R., Jolidon, S., Richter, W. F., Guenzi, A., Girometta, M.-A., Urwyler, H., Huber, W., Thaithong, C. and Peters, W. (1996) 4-Aminoquinoline analogs of chloroquine with shortened side chains retain activity against chloroquine-resistant Plasmodium falciparum. Antimicrob. Agents Chemother. 40: 1846-1854.
99. Ringwald, R., Bickii, J. and Basco, L. (1996) Randomised trial of pyronaridine versus chloroquine for acute uncomplicated falciparum malaria in Africa. Lancet 347: 24-27.
100. Rosenthal, P. J., McKerrow, J. H., Aikawa, M., Nagasawa, H. and Leech, J. H. ( 1988) A malarial cysteine protease is necessary for hemoglobin degradation by Plasmodium falciparum. J. Clin. Invest. 82: 1560-1566.
101. Roth, E. F., Brotman, D. S., Vandenberg, J. P. and Schulman, S. (1986) Malaria pigment dependent error in the estimation of hemoglobin content in Plasmodium falciparum infected red cells: implications for metabolic and biochemical studies of the erythrocytic phases of malaria. Am. J. Trop. Med. Hyg. 35: 906-911.
102. Rotstein, S. H. and Murcko, M. A. (1993) GroupBuild: a fragment-based method for de novo drug design. J. Med. Chem. 36: 1700-1710.
103. Rudzinska, M. A. and Trager, W. (1957) Intracellular phagotrophy by malaria parasites: an electron microscope study of Plasmodium lophurae. J. Protozool. 4: 190-199.
104. Ruscoe, J. E., Jewell, H., Maggs, J. L., O'Neill, P. M., Storr, R. C., Ward, S. A. and Park, B. K. (1995) The effect of chemical substitution on the metabolic activation, metabolic detoxication, and pharmacological activity of amodiaquine in the mouse. J. Pharmacol. Exp. Ther. 273: 393-404.
105. Schueler, F. W. and Cantrell, W. F. (1964) Antagonism of the antimalarial action of chloroquine by ferrihemate and a hypothesis for the mechanism of chloroquine resistance. J. Pharmacol. Exp. Ther. 143: 278-281.
106. Scott, H. V., Tan, W. L. and Barlin, G. B. (1987) Antimalarial activity of Mannich bases derived from 4-(7′-bromo-1′,5′-napthyridin-4′-ylamino)phenol and 4-(7′-Trifluoro methylquinolin-4′-ylamino)phenol against Plasmodium falciparum in vitro. Ann. Trop. Med. Parasitol. 81: 85-93.
107. Shalmiev, G. and Ginsburg, H. (1993) The susceptibility of the human malaria parasite Plasmodium falciparum to quinoline-containing drugs is correlated to the lipid composition of the infected erythrocyte membranes. Biochem. Pharmacol. 46: 365-374.
108. Sherman, I. W. (1977) Amino acid metabolism and protein synthesis in malarial parasites. Bull. WHO 55: 265-276.
109. Sherman, I. W. (1979) Biochemistry of Plasmodium (malarial parasites). Microbiol. Rev. 43: 453-494.
110. 14C-amino acids by malaria (Plasmodium lophurae). Int. J. Biochem. 1: 635-637.
111. Slater, A. F. and Cerami, A. (1992) Inhibition by chloroquine of a novel heme polymerase enzyme activity in malaria trophozoites. Nature 355: 167-169.
112. Slomianny, C., Prensier, G. and Vivier, E. (1982) Studies on the mechanism of hemoglobin digestion by the malaria parasite Plasmodium falciparum. Mol. Biochem. Parasitol. 5: 695-702.
113. Steck, E. A. (1972) The Chemotherapy of Protozoan Diseases, Vol. 3, Section 4. Walter Reed Army Institute of Research, Washington, DC.
114. Steck, E. A., Hallock, L. L. and Suter, C. M. (1948) Quinolines VI: some 4-aminoquinoline derivatives. J. Am. Chem. Soc. 70: 4063.
115. Surolia, N. and Padmanaban, G. (1991) Chloroquine inhibits heme-dependent protein-synthesis in Plasmodium falciparum. Proc. Natl. Acad. Sci. USA 88: 4786-4790.
116. Surrey, A. R. and Hammer, H. F. (1950) The preparation of 7-chloro-4-(4-N-ethyl-N-β-hydroxyethylamino)-1-methylbutylamino)-qu inoline. J. Am. Chem. Soc. 72: 1814-1815.
117. Thompson, P. E. and Werbel, L. M. (1972) 4-Aminoquinolines. In: Medicinal Chemistry: A Series of Monographs, Vol. 12, Antimalarial Agents, pp. 150-190, de Stevens, G. (ed.) Academic Press, New York.
118. Thompson, P. E., Weston, K., Glazko, A. J., Fisken, R. A., Reutner, T. A., Bayles, A. and Weston, J. K. (1958) Laboratory studies on amopyroquin (propaquin): an antimalarial compound. Antibiot. Chemother. 8: 450-460.
119. Vander Jagt, D. L., Hunsaker, L. A., Campos, N. M. and Scaletti, J. V. (1992) Localisation and characterisation of hemoglobin-degrading proteinases from the malarial parasite Plasmodium falciparum. Biochim. Biophys. Acta 1122: 256-264.
120. Vennerstrom, J. L., Ellis, W. Y., Ager, A. L., Andersen, S. L., Gerena, L. and Milhous, W. K. (1992) Bisquinolines 1: N,N-bis (7-chloroquinolin-4-yl) alkane diamines with potential activity against chloroquine resistant parasites. J. Med. Chem. 35: 2129-2134.
121. Verdier, F., Le Bras, J., Clavier, F., Hatin, I. and Blayo, M. (1985) Chloroquine uptake by Plasmodium falciparum-infected human erythrocytes during in vitro culture and its relationship to chloroquine resistance. Antimicrob. Agents Chemother. 27: 561-564.
122. Vermeulen, N. P., Bessems, J. G. and van de Stratt, R. (1992) Molecular aspects of paracetamol-induced hepatotoxicity and its mechanism based prevention. Drug Metab. Rev. 24: 367-407.
123. Ward, S. A. (1992) In: Therapeutic Drugs, Supplement 1, Halofantrine, pp. 110-113, Dollery, C. (ed.) Churchill Livingstone, New York.
124. Warhurst, D. C. (1969) Some aspects of the antimalarial action of chloroquine. Trans. R. Soc. Trop. Med. Hyg. 63: 4.
125. Warhurst, D. C. (1981) The quinine-haemin interaction and its relationship to antimalarial activity. Biochem. Pharmacol. 30: 3323-3327.
126. Warhurst, D. C. (1987) Antimalarial interaction with ferriprotoporphyrin IX monomer and its relationship to activity of blood schizonticides. Ann. Trop. Med. Parasitol. 81: 65-67.
127. Warhurst, D. C. and Williamson, J. (1968) Electrophoretic fractionation of ribonucleic acid from Plasmodium knowlesi. Trans. R. Soc. Trop. Med. Hyg. 62: 3-4.
128. Warhurst, D. C. and Williamson, J. (1979) Ribonucleic acid from Plasmodium knowlesi before and after chloroquine treatment. Chem. Biol. Interact. 2: 89-106.
129. Watkins, W. M., Sixsmith, D. G., Spencer, H. G., Boriga, D. A., Karjuki, D. M., Kipingor, T. and Koech, D. K. (1984) Effectiveness of amodiaquine as a treatment for chloroquine-resistant Plasmodium falciparum infections in Kenya. Lancet i: 357-359.
130. Wellems, T. E. (1991) Molecular genetics of drug resistance in Plasmodium falciparum malaria. Parasitol. Today 7: 110-112.
131. Werbel, L. M., Cook, P. D., Elslager, E. F., Hung, J. H., Johnson, J. L., Kesten, S. J., McNamara, D. J., Ortwine, D. F. and Worth, D. F. (1986) Synthesis, antimalarial activity and quantitative structure-activity relationships of tebuquine and a series of related 5-[(7-chloro-4-quinolinyl)amino]-3-[(alkylamino)methyl] [1,1′-biphenyl]-2-ols and N omega-oxides. J. Med. Chem. 29: 924-939.
132. Werbel, L. M., Kesten, S. J. and Turner, W. R. (1993) Structure-activity-relationships of antimalarial indolo[3,2-c]quinolines [1, 2]. Eur. J. Med. Chem. 28: 837-852.
133. White, N. J., Looareesuwan, S., Edwards, G., Phillips, R. E., Karbwang, J., Nicholl, D. D., Bunch, C. and Warrel, D. A. (1987) Pharmacokinetics of intravenous amodiaquine. Br. J. Clin. Pharmacol. 23: 127-135.
134. WHO Practical Chemotherapy of Malaria (1990) Technical Report Series No. 805. World Health Organisation, Geneva.
135. Winstanley, P. A., Edwards, I. G., Orme, M. L. and Breckenridge, A. M. (1987) Effect of dose size on amodiaquine pharmacokinetics after oral administration. Eur. J. Clin. Pharmacol. 33: 331-333.
136. Wiselogle, F. Y. (ed.) (1946) A Survey of Antimalarial Drugs, 1941, Vols. 1 and 2. Edwards, Ann Arbor.
137. Xu, D. Y., Shen, N. C., Li, Y. T., Yin, X. S., Chen, Q., Yin, M. Q., Li, J., He, S. F., Chou, M. X. and Gone, J. Z. (1990) Studies on the new antimalarial drug hydroxypiperaquine and its phosphate. In: Antimalarial Drug Development in China, pp. 135-148, Shen, X. (ed.) National Institute of Pharmaceutical Research, Beijing.
138. Yayon, A. and Ginsburg, H. (1983) Chloroquine inhibits the degradation of endocytic vesicles in human malaria parasites. Cell. Biol. Int. Rep. 7: 895-901.
139. Yayon, A., Cabantchik, Z. I. and Ginsburg, H. (1984a) Identification of the acidic compartment of Plasmodium falciparum-infected human erythrocytes as the target of the antimalarial drug chloroquine. EMBO J. 3: 2695-2700.
140. Yayon, A., Timberg, R., Friedman, S. and Ginsburg, H. (1984b) Effects of chloroquine on the feeding mechanism of the intraerythrocytic human malarial parasite Plasmodium falciparum. J. Protozool. 31: 367-372.
141. Yayon, A., Cabantchik, Z. I. and Ginsburg, H. (1985) Susceptibility of human malaria parasites to chloroquine is pH dependent. Proc. Natl. Acad. Sci. USA 82: 2784-2788.
142. Yennawar, H. P. and Viswamitra, M. A. (1991) Steric and rotational constraints in the X-ray structure of the antimalarial drug amodiaquine. Gurr. Sci. 61: 39-43.
143. Zarchin, S., Krugliak, M. and Ginsburg, H. (1986) Digestion of the host erythrocyte by malarial parasites is the primary target for quinoline-containing antimalarials. Biochem. Pharmacol. 35: 2435-2442.
144. Zhang, Y. and Hempleman, J. (1987) Lysis of malaria parasites and erythrocytes by FPIX-chloroquine and the inhibition of this effect by proteins. Biochem. Pharmacol. 36: 1267-1273.